Review of the MASS II study

Dr. TNews for Professionals, Professionals Leave a Comment

MASS II is yet another study that shows the benefits of CABG compared to the limits of PCI as a viable long term strategy in stable patients with Coronary Artery Disease. This evidence adds to the ever growing body of literature promulgating the same in other risk groups (SYNTAX, SYNTAX-3 Analysis, BARI-2D, OAT trial, PCI vs. CABG – A Current …